Neoadjuvant endocrine therapy for ER+ DCIS reduces the size of disease and allows BCS with a low re-excision rate Christopher W.J. Cartlidge,Neil Johns, Teresa Fernandez-Cuadrado,J. Michael DixonEjso（2018）引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
